Exploring the effects of probiotics on olanzapine-induced metabolic syndrome through the gut microbiota
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Exploring the effects of probiotics on olanzapine-induced metabolic syndrome through the gut microbiota ; volume:16 ; number:1 ; day:21 ; month:12 ; year:2024 ; pages:1-23 ; date:12.2024
Gut pathogens ; 16, Heft 1 (21.12.2024), 1-23, 12.2024
- Creator
-
Mushraf, Syed
Chawla, Kiran
Fayaz, Shaik Mohammed Abdul
Mathew, Aranjani Jesil
Reddy, Gayam Prasanna Kumar
Kappettu Gadahad, Mohandas Rao
Shenoy, Padmaja A.
Devi, Vasudha
Adiga, Shalini
Nayak, Veena
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13099-024-00664-2
- URN
-
urn:nbn:de:101:1-2503022117384.579339430234
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:22 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Mushraf, Syed
- Chawla, Kiran
- Fayaz, Shaik Mohammed Abdul
- Mathew, Aranjani Jesil
- Reddy, Gayam Prasanna Kumar
- Kappettu Gadahad, Mohandas Rao
- Shenoy, Padmaja A.
- Devi, Vasudha
- Adiga, Shalini
- Nayak, Veena
- SpringerLink (Online service)
Other Objects (12)
Probiotics and microbiota composition
Gut microbiota, probiotics and diabetes
Gut microbiota as a potential target of metabolic syndrome: the role of probiotics and prebiotics
Targeting the microbiome: from probiotics to fecal microbiota transplantation
Probiotics and the Microbiota-Gut-Brain Axis: Focus on Psychiatry
Olanzapine: The Game-Changer “Antiemetic”
Intestinal microbiota in human health and disease: the impact of probiotics
Microbiota and neurologic diseases: potential effects of probiotics
The intestinal microbiota in metabolic disease
Zebrafish shares common metabolic pathways with mammalian olanzapine-induced obesity
Probiotics in human gut microbiota can degrade host glycosaminoglycans
Olanzapine-induced mania
Probiotics and microbiota composition
Gut microbiota, probiotics and diabetes
Gut microbiota as a potential target of metabolic syndrome: the role of probiotics and prebiotics
Targeting the microbiome: from probiotics to fecal microbiota transplantation
Probiotics and the Microbiota-Gut-Brain Axis: Focus on Psychiatry
Olanzapine: The Game-Changer “Antiemetic”
Intestinal microbiota in human health and disease: the impact of probiotics
Microbiota and neurologic diseases: potential effects of probiotics
The intestinal microbiota in metabolic disease
Zebrafish shares common metabolic pathways with mammalian olanzapine-induced obesity
Probiotics in human gut microbiota can degrade host glycosaminoglycans
Olanzapine-induced mania
Probiotics and microbiota composition
Gut microbiota, probiotics and diabetes
Gut microbiota as a potential target of metabolic syndrome: the role of probiotics and prebiotics
Targeting the microbiome: from probiotics to fecal microbiota transplantation
Probiotics and the Microbiota-Gut-Brain Axis: Focus on Psychiatry
Olanzapine: The Game-Changer “Antiemetic”
Intestinal microbiota in human health and disease: the impact of probiotics
Microbiota and neurologic diseases: potential effects of probiotics
The intestinal microbiota in metabolic disease
Zebrafish shares common metabolic pathways with mammalian olanzapine-induced obesity
Probiotics in human gut microbiota can degrade host glycosaminoglycans